MARY DEK

Allopathic & Osteopathic Physicians|Pediatrics ELKHORN, NE NPI 1124187984

General Payments — all program years on this page

$2,572.24

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 147
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $382.93 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $382.9320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $435.8923
2019 $284.0820
2020 $49.393
2021 $534.4325
2022 $492.8329
2023 $392.6927
2024 $382.9320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082666115 Neos Therapeutics, LP $13.64 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082667809 Neos Therapeutics, LP $16.50 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082678277 Neos Therapeutics, LP $13.67 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105414877 AstraZeneca Pharmaceuticals LP $23.83 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105709684 AstraZeneca Pharmaceuticals LP $19.33 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116694085 GlaxoSmithKline, LLC. $13.09 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125632870 Seqirus USA Inc $29.33 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126627915 kaleo, Inc. $15.27 01/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128742246 SANOFI PASTEUR INC. $16.76 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131246509 PFIZER INC. $16.38 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139719804 SANOFI-AVENTIS U.S. LLC $23.85 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139719808 SANOFI-AVENTIS U.S. LLC $22.00 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139719832 SANOFI-AVENTIS U.S. LLC $13.56 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139719852 SANOFI-AVENTIS U.S. LLC $18.45 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141977138 Merck Sharp & Dohme LLC $15.46 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146284440 IRONSHORE PHARMACEUTICALS INC. $16.65 06/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147212667 Tris Pharma Inc $18.62 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147778966 Supernus Pharmaceuticals, Inc. $22.79 07/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147778968 Supernus Pharmaceuticals, Inc. $30.65 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147894783 Supernus Pharmaceuticals, Inc. $23.10 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.